Skip to main content

Table 2 Summary of the management and outcomes of patients with ophthalmic JXG

From: Clinicopathological study of ophthalmic cutaneous and mucocutaneous non-langerhans cell histiocytic lesions

Variables

Eyelid

(5 patients)

Orbit

(1 patient)

Conjunctiva/limbus

(2 patients)

Iris

(3 patient)

Choroid

(1 patient)

Overall

(11 patients)

Therapy/intervention, number

      

 Surgical b

5

1

2

3

1

11

 Medical c

0

0

0

3

0

3

Duration of follow-up, months

      

 Median

4.5 years

15 years

6 months

1 year

9 months

14.5 months

Recurrence/progression, number

      

 Absent

5

1

2

3

1

11

  1. b Includes excisional biopsies (single or multiple), debulking procedures, and enucleation
  2. c Includes topical steroids and atropine